Investegate |Indivior PLC Announcements | Indivior PLC: First patient enrolled in AEF0117 Phase 2b study
Investegate announcements from Indivior PLC, First patient enrolled in AEF0117 Phase 2b study
Stay updated with breaking news from Study Assessing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from Indivior PLC, First patient enrolled in AEF0117 Phase 2b study
STOCKHOLM, May 18, 2022 /PRNewswire/ -- Minister of State for Business, Energy and Clean Growth, Greg Hands, visited marine energy company Minesto last week where he was introduced to the technology
STOCKHOLM, May 18, 2022 /PRNewswire/ -- Minister of State for Business, Energy and Clean Growth, Greg...
Investegate announcements from NOVARTIS AG CHF0.50(REGD), Novartis data highlight efficacy of Piqray® in HR+/HER2- metastatic breast cancer with a PIK3CA driver mutation immediately post-CDK4/6i
/PRNewswire/ -- Novartis today announced new Piqray® (alpelisib) data indicating benefit across a broad range of patient and disease characteristics as seen in...